Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

Heini M.L. Kallio, Reija Hieta, Leena Latonen, Anniina Brofeldt, Matti Annala, Kati Kivinummi, Teuvo L. Tammela, Matti Nykter, William B. Isaacs, Hans G. Lilja, G. Steven Bova, Tapio Visakorpi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases'. Together they form a unique fingerprint.

Medicine & Life Sciences